The trend of increasing circulating levels of inflammatory markers (TNF-α, CRP and IL-1β) and NLRP3 levels with respect to increasing MetS components in the three study groups in females is depicted in Figure 1. This evidence concerns the gene CRP and metabolic syndrome.